[yieldcrv]

the pricing is partially due to a lack of collective negotiation

the government programs carry a lot of weight as a large client but are currently barred from negotiating on prices

part of some US universal healthcare proposals are to just allow existing government programs to negotiate on prices, while simultaneously extending coverage to more people

[qwytw]

It costs about $7000 in Europe (the price seems to be similar in different country even though there is no EU wide collective negotiation).

The price in the US seems to be around double in the US. But maybe that just pharma companies do PPP adjusted pricing? e.g. it seems to cost ~1500 in India for instance. Americans are simply much richer and also significantly more on healthcare than people in other countries.

[haldujai]

> It costs about $7000 in Europe (the price seems to be similar in different country even though there is no EU wide collective negotiation).

That seems like a monthly price? The treatment regimen in this study is daily for 3 years.

It's hard to find out what drug prices really cost as there are a lot of discounts and negotiations behind the scenes but the best source in this instance would be a cost-effectiveness study which uses local data and happens to be a hot-topic in every national cancer society so is widely available.

EU and US pricing isn't too far off with both being ~130k USD a year give or take.

> it seems to cost ~1500 in India for instance.

There were generics, and there probably still are in parts of the world but they're technically "illegal". AstraZeneca shut down a few and there are pending countersuits against them.

https://www.fiercepharma.com/pharma/astrazeneca-staves-last-...